A Census of Human Cancer Genes

Overview

Journal Nat Rev Cancer

Specialty Oncology

Date 2004 Mar 3

PMID 14993899

Citations 1569

Authors

P Andrew Futreal

Lachlan Coin

Mhairi Marshall

Thomas Down

Timothy Hubbard

Richard Wooster

Nazneen Rahman

Michael R Stratton

Affiliations

Soon will be listed here.

Citing Articles

Frequency and treatment outcomes of chest wall masses: a 10-year report.

Rezaei R, Amir Fakhrian S, Mehri A, Fattahi Masoum S Kardiochir Torakochirurgia Pol. 2025; 21(4):223-228.

PMID: 39781434 PMC: 11704756. DOI: 10.5114/kitp.2024.145848.

Senescence Reprogramming by MTHFD2 Deficiency Facilitates Tumor Progression.

Fang Z, Pei W, Wu Q, Niu T, Dong C, Wu M J Cancer. 2024; 15(20):6577-6593.

PMID: 39668825 PMC: 11632999. DOI: 10.7150/jca.99168.

Mapping the functional network of human cancer through machine learning and pan-cancer proteogenomics.

Shi Z, Lei J, Elizarraras J, Zhang B Nat Cancer. 2024; 6(1):205-222.

PMID: 39663389 DOI: 10.1038/s43018-024-00869-z.

CancerPro: deciphering the pan-cancer prognostic landscape through combinatorial enrichment analysis and knowledge network insights.

Wang Z, Yuan Y, Wang Z, Zhang W, Chen C, Duan Z NAR Genom Bioinform. 2024; 6(4):lqae157.

PMID: 39633722 PMC: 11616677. DOI: 10.1093/nargab/lqae157.

ECGA: A web server to explore and analyze extrachromosomal gene in cancer.

Zhou N, Peng L, Zhang Z, Luo Q, Sun H, Bao J Comput Struct Biotechnol J. 2024; 23:3955-3966.

PMID: 39582892 PMC: 11584521. DOI: 10.1016/j.csbj.2024.11.009.

References

Heinrich M, Corless C, Duensing A, McGreevey L, Chen C, Joseph N . PDGFRA activating mutations in gastrointestinal stromal tumors. Science. 2003; 299(5607):708-10. DOI: 10.1126/science.1079666. View

Tognon C, Knezevich S, Huntsman D, Roskelley C, Melnyk N, Mathers J . Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma. Cancer Cell. 2002; 2(5):367-76. DOI: 10.1016/s1535-6108(02)00180-0. View

Shih C, Shilo B, Goldfarb M, Dannenberg A, Weinberg R . Passage of phenotypes of chemically transformed cells via transfection of DNA and chromatin. Proc Natl Acad Sci U S A. 1979; 76(11):5714-8. PMC: 411720. DOI: 10.1073/pnas.76.11.5714. View

Krontiris T, Cooper G . Transforming activity of human tumor DNAs. Proc Natl Acad Sci U S A. 1981; 78(2):1181-4. PMC: 319971. DOI: 10.1073/pnas.78.2.1181. View

Tabin C, Bradley S, Bargmann C, Weinberg R, Papageorge A, Scolnick E . Mechanism of activation of a human oncogene. Nature. 1982; 300(5888):143-9. DOI: 10.1038/300143a0. View

Reddy E, Reynolds R, Santos E, Barbacid M . A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene. Nature. 1982; 300(5888):149-52. DOI: 10.1038/300149a0. View

Baker S, Preisinger A, Jessup J, Paraskeva C, Markowitz S, WILLSON J . p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res. 1990; 50(23):7717-22. View

Wong A, Ruppert J, Bigner S, Grzeschik C, Humphrey P, Bigner D . Structural alterations of the epidermal growth factor receptor gene in human gliomas. Proc Natl Acad Sci U S A. 1992; 89(7):2965-9. PMC: 48784. DOI: 10.1073/pnas.89.7.2965. View

Bongarzone I, Monzini N, Borrello M, Carcano C, Ferraresi G, Arighi E . Molecular characterization of a thyroid tumor-specific transforming sequence formed by the fusion of ret tyrosine kinase and the regulatory subunit RI alpha of cyclic AMP-dependent protein kinase A. Mol Cell Biol. 1993; 13(1):358-66. PMC: 358915. DOI: 10.1128/mcb.13.1.358-366.1993. View

10.

Fishel R, Lescoe M, Rao M, Copeland N, Jenkins N, Garber J . The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell. 1993; 75(5):1027-38. DOI: 10.1016/0092-8674(93)90546-3. View

11.

Leach F, Nicolaides N, Papadopoulos N, Liu B, Jen J, Parsons R . Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell. 1993; 75(6):1215-25. DOI: 10.1016/0092-8674(93)90330-s. View

12.

Parsons R, Li G, Longley M, Fang W, Papadopoulos N, Jen J . Hypermutability and mismatch repair deficiency in RER+ tumor cells. Cell. 1993; 75(6):1227-36. DOI: 10.1016/0092-8674(93)90331-j. View

13.

Kamb A, Gruis N, Liu Q, Harshman K, Tavtigian S, STOCKERT E . A cell cycle regulator potentially involved in genesis of many tumor types. Science. 1994; 264(5157):436-40. DOI: 10.1126/science.8153634. View

14.

Futreal P, Liu Q, Cochran C, Harshman K, Tavtigian S, Bennett L . BRCA1 mutations in primary breast and ovarian carcinomas. Science. 1994; 266(5182):120-2. DOI: 10.1126/science.7939630. View

15.

Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L . A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science. 1995; 268(5218):1749-53. DOI: 10.1126/science.7792600. View

16.

Merlo A, Herman J, Mao L, Lee D, Gabrielson E, Burger P . 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med. 1995; 1(7):686-92. DOI: 10.1038/nm0795-686. View

17.

Ohta M, Inoue H, Cotticelli M, Kastury K, Baffa R, Palazzo J . The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell. 1996; 84(4):587-97. DOI: 10.1016/s0092-8674(00)81034-x. View

18.

Lancaster J, Wooster R, Mangion J, Phelan C, Cochran C, Gumbs C . BRCA2 mutations in primary breast and ovarian cancers. Nat Genet. 1996; 13(2):238-40. DOI: 10.1038/ng0696-238. View

19.

Sidhar S, Clark J, Gill S, Hamoudi R, Crew A, Gwilliam R . The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene. Hum Mol Genet. 1996; 5(9):1333-8. DOI: 10.1093/hmg/5.9.1333. View

20.

Kane M, Loda M, Gaida G, Lipman J, Mishra R, Goldman H . Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res. 1997; 57(5):808-11. View